leading cancer immune therapy developer

Next Generation CAR-T Technologies

Multiplex CARs; CAR-T to overcome tumor microenvironment

Gene Editing Platform

to develop universal CAR-Ts from healthy donors

Novel Co-Stimulatory Factors

CAR-T with novel co-stimulatory factors